跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,147 条关于
“P300/CBP”
全部
4,147
临床试验
3,015
药物
774
机构
16
资讯
342
去年
Astex Pharmaceuticals Highlights Preclinical and Clinical Advances at EORTC-NCI-AACR Symposium
去年
CellCentric Secures $120 Million Series C Funding to Advance Oral Multiple Myeloma Treatment
去年
First-in-Class CBP/p300 Inhibitor TT125-802 Shows Promise in Treatment-Resistant NSCLC
去年
CellCentric Completes Enrollment for Inobrodib Dose Optimization Study in Multiple Myeloma
9个月前
CellCentric's Inobrodib Shows 60-75% Response Rates in Heavily Pretreated Multiple Myeloma Patients
去年
TOLREMO Therapeutics Strengthens Leadership with Key Appointments as TT125-802 Shows Clinical Promise
3个月前
Advancing Pediatric Rhabdomyosarcoma Therapeutics: FGFR4, MYOD1, and Novel Degrader Strategies Take Center Stage
去年
Pathos AI Initiates Phase 1b/2a Trial of Pocenbrodib for Metastatic Castration-Resistant Prostate Cancer
5个月前
CellCentric Launches Pivotal Phase 2 Trial of Inobrodib Combination for Relapsed Multiple Myeloma
2个月前
Histone Lactylation Emerges as Key Epigenetic Link Between Glycolysis and Ferroptosis in Neurological Diseases
第 1 页,共 35 页
上一页
下一页